Introduction: Group B β haemolytic streptococcus (GBS) is a colonizer of the female genital tract and a known cause of neonatal infections. Identification of GBS colonization in pregnancy is the key to prevent such infections. Published data regarding GBS colonization in pregnancy are limited in Sri Lanka. Objectives: The objectives of this study were to determine the prevalence of GBS colonization in pregnancy, to compare vaginal and rectal colonization rates and to find out the antibiotic susceptibility of the GBS isolates. Methods: Lower vaginal and rectal swabs were collected separately from 100 pregnant women of 35 to 37 weeks gestation attending the obstetric clinics at Teaching Hospital Peradeniya from August to November 2011. Vaginal and rectal swabs were separately enriched using Todd Hewitt broth supplemented with gentamicin and nalidixic acid and incubated at 35-37 o C. Following overnight incubation, the enriched broth was subcultured onto blood agar. Suspected colonies were identified with Gram stain, catalase and Lancefield's grouping. Susceptibility testing was performed using the Stokes method. Results: GBS colonization in the study sample was found to be 30%. GBS were recovered from both vaginal and rectal swabs in 20%. It was isolated only from vaginal swabs in 4% and only from rectal swabs in 6%. Rectal GBS colonization was 26% and higher than the vaginal colonization rate (24%). The sensitivity to penicillin was found to be 100% while the sensitivity to erythromycin and clindamycin were 63.3% and 30% respectively. Conclusion: This study implies the need for routine GBS screening in pregnancy and the importance of collecting both vaginal and rectal swabs for GBS screening.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.